UIS Student and Faculty Research Explores Appeal of Novel Nicotine Products

One of the key research areas for Dr. H. A. Bolívar at the University of Illinois Springfield (UIS) is addictive behavior, with a particular focus on nicotine and tobacco use. In a recent project, Dr. Bolívar's lab has turned its attention to the rising popularity and potential risks and benefits of smokeless nicotine pouches made with synthetic nicotine, such as Zyn and Velo.

These novel products are marketed as cleaner alternatives to traditional tobacco, especially combusted products like cigarettes. While they may offer a potential path to reducing tobacco-related harm, a crucial question remains: Are current tobacco users actually interested in switching to these alternatives?

To explore this, Dr. Bolívar and their team conducted an online survey targeting individuals who currently use nicotine and tobacco products. The study assessed participants’ perceptions of these synthetic nicotine pouches and whether they might consider using them in the near future.

An intriguing insight emerged from the data: although many participants found the idea of these products at least somewhat appealing, most were not particularly likely to adopt them within the next year. This suggests a gap between perception and behavioral intent, underscoring the need for further research into the factors influencing product adoption among smokers and nicotine users.

The project is supported by an internal grant from the University of Illinois System, and it also highlights valuable student involvement in research. UIS student Grace Lehmann is collaborating closely with Dr. Bolívar on this study. Together, they presented their findings at the 2025 Midwestern Psychological Association conference in Chicago, IL. Their poster, titled “Appeal and Interest in Novel Oral Nicotine Products Among Current Tobacco Users,” drew interest from fellow researchers and professionals in the field.